Roche Holding | ROG - Passivo Circulante





Passivo Circulante Alterar Data
AbbVie USD 42.1B 1.19B 2026-03
Alcon AG USD 3B 45M 2026-03
Almirall EUR 323.65M 26.99M 2026-06
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 33.46B 875M 2026-03
Biogen USD 3.92B 918.2M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Eli Lilly USD 36.63B 1.41B 2026-03
Fresenius EUR 8.38B 1.18B 2025-12
Fresenius Medical Care EUR 6.73B 484.42M 2026-03
Genmab DKK 1.43B 686M 2025-12
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 21.53B 895M 2026-06
GRIFOLS EUR 2.12B 105M 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lakefront Biotherapeutics EUR 100.42M 52.44M 2026-03
Lonza CHF 3.57B 421M 2025-12
Merck EUR 9.35B 307M 2026-03
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.75B 374M 2026-06
Orion EUR 454.5M 344.1M 2026-06
Pfizer USD 34.35B 2.64B 2026-03
Philips EUR 7.42B 8M 2026-06
Recordati EUR 1.37B 315.51M 2026-03
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
UCB EUR 4.4B 470M 2025-12